实时全球研报
Chervon (2285.HK): Upgrade to Buy from Sell on Earnings Recovery After Easing US Tariffs
研报英文原文证据摘录
Chervon (2285.HK): Upgrade to Buy from Sell on Earnings Recovery After Easing US Tariffs
Action |
01 Jul 2026 11:19:25 ET │ 15 pages
Chervon (2285.HK)
Upgrade to Buy from Sell on Earnings Recovery After Easing US Tariffs
CITI'S TAKE
We raise our 2026-28E earnings estimates by 5-14% thanks to easing US
tariffs pressure in 2026 versus 2025. Our TP rises to HK$24 from HK$17.5
after the earnings upgrade and rollover to 11x 2027E PE from prior 2026E. Buy ↑ from Sell
2026 is the first year of Chervon’s earnings recovery, thus 2027 is a better
base year to reflect the actual operation assuming no tariff change. We also Catalyst Watch: Upside
open a 30-day positive catalyst watch based on anticipation of 1) resuming Price (30 Jun 26 16:10) HK$16.60
double-digit growth for the top line and core earnings in 1H26E results; 2) Target price HK$24.00↑
mgmt. presenting a rosy outlook for 2H26E during the upcoming results
briefing. We model 3-year earnings CAGR of 20% through 2028E. We thus from HK$17.50
upgrade to Buy from Sell after the stock’s sharp >32% fall since end-Feb. Expected share price return 44.6%
Expected dividend yield 3.1%
Set for earnings recovery from 2026E – in view of the termination of IEEPA tariffs Expected total return 47.6%on 24 Feb 2026, which were then replaced by a temporary tariff Section 122 of 10%
for 150 days till 25 July. The US admin has proposed additional tariff of up to 12.5% Market Cap HK$8,483M
under Section 301, which is likely to take effect from July to replace that temporary US$1,082M
tariff of 10%, in our view. In general, the additional tariff of up to 12.5% should be
well below reciprocal tariff (20% for most ASEAN countries) under IEEPA. This
should position Chervon to resume positive earnings growth from 2026E (our
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器